Titre : Produits du tabac

Produits du tabac : Questions médicales fréquentes

Termes MeSH sélectionnés :

Social Communication Disorder

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment diagnostiquer une dépendance au tabac ?

Le diagnostic repose sur des questionnaires d'auto-évaluation et l'observation des symptômes de sevrage.
Dépendance au tabac Diagnostic médical
#2

Quels tests pour évaluer les effets du tabac ?

Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets du tabac.
Tests de fonction pulmonaire Tabagisme

Symptômes 2

#1

Quels sont les symptômes d'une intoxication au tabac ?

Les symptômes incluent nausées, vertiges, maux de tête et palpitations cardiaques.
Intoxication au tabac Symptômes
#2

Comment le tabac affecte-t-il la respiration ?

Le tabac provoque une toux chronique, un essoufflement et une diminution de la capacité pulmonaire.
Tabagisme Maladies respiratoires

Prévention 2

#1

Comment prévenir le tabagisme chez les jeunes ?

L'éducation, les campagnes de sensibilisation et les politiques anti-tabac sont essentielles.
Prévention du tabagisme Éducation à la santé
#2

Les lois anti-tabac sont-elles efficaces ?

Oui, elles réduisent la consommation de tabac et protègent les non-fumeurs de l'exposition.
Législation anti-tabac Santé publique

Traitements 2

#1

Quels traitements existent pour arrêter de fumer ?

Les traitements incluent les substituts nicotiniques, les médicaments et la thérapie comportementale.
Sevrage tabagique Traitement médicamenteux
#2

Les thérapies comportementales sont-elles efficaces ?

Oui, elles augmentent les chances d'arrêter de fumer en modifiant les comportements liés au tabagisme.
Thérapie comportementale Dépendance au tabac

Complications 2

#1

Quelles sont les complications du tabagisme ?

Les complications incluent le cancer, les maladies cardiovasculaires et les maladies respiratoires chroniques.
Complications du tabagisme Maladies cardiovasculaires
#2

Le tabac augmente-t-il le risque de cancer ?

Oui, le tabac est un facteur de risque majeur pour plusieurs types de cancer, notamment le poumon.
Cancer du poumon Tabagisme

Facteurs de risque 2

#1

Quels sont les facteurs de risque du tabagisme ?

Les facteurs incluent l'âge, l'environnement social, et l'exposition à des antécédents familiaux.
Facteurs de risque Tabagisme
#2

Le stress influence-t-il la consommation de tabac ?

Oui, le stress peut augmenter la consommation de tabac chez les individus dépendants.
Stress Dépendance au tabac
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Produits du tabac : Questions médicales les plus fréquentes", "headline": "Produits du tabac : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Produits du tabac : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-18", "dateModified": "2025-02-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Produits du tabac" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dispositifs pour fumer", "url": "https://questionsmedicales.fr/mesh/D000074602", "about": { "@type": "MedicalCondition", "name": "Dispositifs pour fumer", "code": { "@type": "MedicalCode", "code": "D000074602", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.767" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Tabac sans fumée", "alternateName": "Tobacco, Smokeless", "url": "https://questionsmedicales.fr/mesh/D014030", "about": { "@type": "MedicalCondition", "name": "Tabac sans fumée", "code": { "@type": "MedicalCode", "code": "D014030", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.767.844.500" } } }, { "@type": "MedicalWebPage", "name": "Tabac pour pipe à eau", "alternateName": "Tobacco, Waterpipe", "url": "https://questionsmedicales.fr/mesh/D000073846", "about": { "@type": "MedicalCondition", "name": "Tabac pour pipe à eau", "code": { "@type": "MedicalCode", "code": "D000073846", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.767.844.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Produits du tabac", "alternateName": "Tobacco Products", "code": { "@type": "MedicalCode", "code": "D062789", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Takahiro Tabuchi", "url": "https://questionsmedicales.fr/author/Takahiro%20Tabuchi", "affiliation": { "@type": "Organization", "name": "Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, Japan." } }, { "@type": "Person", "name": "Jennifer B Unger", "url": "https://questionsmedicales.fr/author/Jennifer%20B%20Unger", "affiliation": { "@type": "Organization", "name": "Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America." } }, { "@type": "Person", "name": "Pamela M Ling", "url": "https://questionsmedicales.fr/author/Pamela%20M%20Ling", "affiliation": { "@type": "Organization", "name": "Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California." } }, { "@type": "Person", "name": "Silvano Gallus", "url": "https://questionsmedicales.fr/author/Silvano%20Gallus", "affiliation": { "@type": "Organization", "name": "Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy." } }, { "@type": "Person", "name": "Jessica L Barrington-Trimis", "url": "https://questionsmedicales.fr/author/Jessica%20L%20Barrington-Trimis", "affiliation": { "@type": "Organization", "name": "Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America. Electronic address: jtrimis@usc.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Usefulness of the autism spectrum quotient (AQ) in screening for autism spectrum disorder and social communication disorder.", "datePublished": "2023-11-13", "url": "https://questionsmedicales.fr/article/37957611", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12888-023-05362-y" } }, { "@type": "ScholarlyArticle", "name": "Enhancing Pragmatic Language skills for Young children with Social communication difficulties (E-PLAYS-2) trial: study protocol for a cluster-randomised controlled trial evaluating a computerised intervention to promote communicative development and collaborative skills in young children.", "datePublished": "2024-05-13", "url": "https://questionsmedicales.fr/article/38741221", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40359-024-01749-y" } }, { "@type": "ScholarlyArticle", "name": "Exploratory Factor Analysis of the Social Communication Disorder Screener.", "datePublished": "2023-08-29", "url": "https://questionsmedicales.fr/article/37642878", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10803-023-06076-6" } }, { "@type": "ScholarlyArticle", "name": "Prevalence and functional impact of social (pragmatic) communication disorders.", "datePublished": "2022-09-16", "url": "https://questionsmedicales.fr/article/36114685", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jcpp.13705" } }, { "@type": "ScholarlyArticle", "name": "Autism spectrum disorder, social pragmatic communication disorder, developmental language disorder- multimorbidity or mutual exclusivity?", "datePublished": "2024-07-17", "url": "https://questionsmedicales.fr/article/39032223", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajp.2024.104162" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Produits manufacturés", "item": "https://questionsmedicales.fr/mesh/D008420" }, { "@type": "ListItem", "position": 4, "name": "Dispositifs pour fumer", "item": "https://questionsmedicales.fr/mesh/D000074602" }, { "@type": "ListItem", "position": 5, "name": "Produits du tabac", "item": "https://questionsmedicales.fr/mesh/D062789" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Produits du tabac - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Produits du tabac", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Produits du tabac", "description": "Comment diagnostiquer une dépendance au tabac ?\nQuels tests pour évaluer les effets du tabac ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Social+Communication+Disorder#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Produits du tabac", "description": "Quels sont les symptômes d'une intoxication au tabac ?\nComment le tabac affecte-t-il la respiration ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Social+Communication+Disorder#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Produits du tabac", "description": "Comment prévenir le tabagisme chez les jeunes ?\nLes lois anti-tabac sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Social+Communication+Disorder#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Produits du tabac", "description": "Quels traitements existent pour arrêter de fumer ?\nLes thérapies comportementales sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Social+Communication+Disorder#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Produits du tabac", "description": "Quelles sont les complications du tabagisme ?\nLe tabac augmente-t-il le risque de cancer ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Social+Communication+Disorder#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Produits du tabac", "description": "Quels sont les facteurs de risque du tabagisme ?\nLe stress influence-t-il la consommation de tabac ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Social+Communication+Disorder#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dépendance au tabac ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des questionnaires d'auto-évaluation et l'observation des symptômes de sevrage." } }, { "@type": "Question", "name": "Quels tests pour évaluer les effets du tabac ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets du tabac." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication au tabac ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent nausées, vertiges, maux de tête et palpitations cardiaques." } }, { "@type": "Question", "name": "Comment le tabac affecte-t-il la respiration ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Le tabac provoque une toux chronique, un essoufflement et une diminution de la capacité pulmonaire." } }, { "@type": "Question", "name": "Comment prévenir le tabagisme chez les jeunes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation, les campagnes de sensibilisation et les politiques anti-tabac sont essentielles." } }, { "@type": "Question", "name": "Les lois anti-tabac sont-elles efficaces ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles réduisent la consommation de tabac et protègent les non-fumeurs de l'exposition." } }, { "@type": "Question", "name": "Quels traitements existent pour arrêter de fumer ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent les substituts nicotiniques, les médicaments et la thérapie comportementale." } }, { "@type": "Question", "name": "Les thérapies comportementales sont-elles efficaces ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles augmentent les chances d'arrêter de fumer en modifiant les comportements liés au tabagisme." } }, { "@type": "Question", "name": "Quelles sont les complications du tabagisme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent le cancer, les maladies cardiovasculaires et les maladies respiratoires chroniques." } }, { "@type": "Question", "name": "Le tabac augmente-t-il le risque de cancer ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabac est un facteur de risque majeur pour plusieurs types de cancer, notamment le poumon." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du tabagisme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, l'environnement social, et l'exposition à des antécédents familiaux." } }, { "@type": "Question", "name": "Le stress influence-t-il la consommation de tabac ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut augmenter la consommation de tabac chez les individus dépendants." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 12/02/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Jennifer B Unger

4 publications dans cette catégorie

Affiliations :
  • Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.

Pamela M Ling

4 publications dans cette catégorie

Affiliations :
  • Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California.
Publications dans "Produits du tabac" :

Silvano Gallus

3 publications dans cette catégorie

Affiliations :
  • Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Publications dans "Produits du tabac" :

Jessica L Barrington-Trimis

3 publications dans cette catégorie

Affiliations :
  • Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America. Electronic address: jtrimis@usc.edu.

Mary Ann Pentz

3 publications dans cette catégorie

Affiliations :
  • Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.

Rob McConnell

3 publications dans cette catégorie

Affiliations :
  • Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.

Lisa Henriksen

3 publications dans cette catégorie

Affiliations :
  • Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, USA.
Publications dans "Produits du tabac" :

William G Shadel

3 publications dans cette catégorie

Affiliations :
  • RAND Corporation, Pittsburgh, PA, USA.

Joan S Tucker

3 publications dans cette catégorie

Affiliations :
  • RAND Corporation, Santa Monica, CA, USA.

Reinskje Talhout

3 publications dans cette catégorie

Affiliations :
  • National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Elisa Borroni

2 publications dans cette catégorie

Affiliations :
  • Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Publications dans "Produits du tabac" :

Anna Odone

2 publications dans cette catégorie

Affiliations :
  • Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.
  • School of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy.
Publications dans "Produits du tabac" :

Piet A van den Brandt

2 publications dans cette catégorie

Affiliations :
  • Department of Epidemiology, CAPHRI-School for Public Health and Primary Care, Maastricht University Medical Centre, 6211 LK Maastricht, The Netherlands.
  • Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, 6211 LK Maastricht, The Netherlands.
Publications dans "Produits du tabac" :

Giuseppe Gorini

2 publications dans cette catégorie

Affiliations :
  • Oncologic Network, Prevention and Research Institute (ISPRO), 50139 Florence, Italy.
Publications dans "Produits du tabac" :

Alessandra Lugo

2 publications dans cette catégorie

Affiliations :
  • Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Publications dans "Produits du tabac" :

Satomi Odani

2 publications dans cette catégorie

Affiliations :
  • Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, Japan.

Irfan Rahman

2 publications dans cette catégorie

Affiliations :
  • Department of Environmental Medicine, University of Rochester Medical Center, Rochester, United States.

Tess Boley Cruz

2 publications dans cette catégorie

Affiliations :
  • Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.

Robert Urman

2 publications dans cette catégorie

Affiliations :
  • Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.

Sources (10000 au total)

Usefulness of the autism spectrum quotient (AQ) in screening for autism spectrum disorder and social communication disorder.

In the Diagnostic and Statistical Manual and Mental Disorders, Fifth Edition (DSM-5), autism spectrum disorder (ASD) and social (pragmatic) communication disorder (SCD) were described as a new categor... Participants were 127 ASD patients, 52 SCD patients, and 49 NT individuals. Receiver operating characteristic (ROC) analyses were used to examine AQ-J total score cutoff values to distinguish between ... In the ROC analysis for the ASD and NT groups, the area under the curve (AUC) was 0.96, and the optimum cutoff value was 23 points (sensitivity 92.9%, specificity 85.7%). The AUC for the SCD and NT gr... Our findings suggest the usefulness of the AQ-J in screening for ASD and SCD....

Enhancing Pragmatic Language skills for Young children with Social communication difficulties (E-PLAYS-2) trial: study protocol for a cluster-randomised controlled trial evaluating a computerised intervention to promote communicative development and collaborative skills in young children.

A number of children experience difficulties with social communication and this has long-term deleterious effects on their mental health, social development and education. The E-PLAYS-2 study will tes... The aim of the E-PLAYS-2 trial is to establish the effectiveness and cost-effectiveness of care as usual plus the E-PLAYS programme, delivered in primary schools, compared to care as usual. Cluster-ra... The aim of this study is to undertake a final, definitive test of the effectiveness of E-PLAYS when delivered by teaching assistants within schools. The use of technology in game form is a novel appro... ISRCTN 17561417, registration date 19th December 2022.... v1.1 19th June 2023....

Prevalence and functional impact of social (pragmatic) communication disorders.

The aim of this study was to evaluate the Children's Communication Checklist-2 (CCC-2) for measuring social-pragmatic communication deficits and to ascertain their prevalence and functional impact in ... We used parent and teacher responses to the CCC-2 to approximate inclusion (poor social-pragmatic skills) and exclusion (poor structural language skills or autistic symptomatology) criteria for social... Regardless of the diagnostic algorithm used, the resulting prevalence rates for social-pragmatic deficits indicated that very few children had isolated social-communication difficulties (0-1.3%). Howe... A considerable proportion of children in the early years of primary school has social-pragmatic deficits that interfere with behaviour and scholastic activity; however, these rarely occur in isolation...

Communication and Social Interaction Experiences of Youths With Congenital Motor Speech Disorders.

The purpose of this study was to explore the communication and social interaction experiences of adolescents with congenital motor speech disorders due to cerebral palsy or Down syndrome, with the aim... Five male youths (ages 14-18 years) with congenital motor speech disorders and one of their parents participated in face-to-face, semistructured interviews designed to understand communication and soc... Participants described the youths' day-to-day communication experiences, including facilitators and barriers to successful social interactions. Thematic analysis revealed three main themes: (a) strong... Participants reported that the impact of congenital motor speech disorders on social interactions and experiences became more apparent in adolescence than in earlier childhood. Addressing communicatio...

Developmental Profile of Children with Autism Spectrum Disorder Versus Social Communication Disorder: A Pilot Study.

Social Communication Disorder (SCD), introduced in the DSM-5, is distinguished from Autism Spectrum Disorder (ASD) by the absence of restricted and repetitive behaviors or interests (RRBIs).... To compare the adaptive, sensory, communication, and cognitive profiles of children with ASD and SCD.... The assessments of nine children with SCD and ten with ASD were compared with either Fisher's Exact Test or the Mann-Whitney Test. Assessments included the Vineland Adaptive Behavior Scales, the Autis... The total ADOS score and the second subtotal "Restricted and Repetitive Behaviors" were significantly higher (... While ASD and SCD share similarities in communication and pragmatic difficulties, some distinctions have been identified, e.g. in executive functioning and the impact on socialization, which may be li...